| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.9M | — | -47.2% |
| Cost of Revenue | $1.7M | — | +21.1% |
| Gross Profit | $1.2M | — | -70.5% |
| R&D Expense | $912K | — | -65.2% |
| SG&A Expense | $2.7M | — | -47.2% |
| Operating Income | -$3.7M | — | +48.8% |
| Pre-tax Income | -$6.1M | — | -181.3% |
| Income Tax | $22K | — | -76.8% |
| Net Income | -$6.1M | — | -182.6% |
| EPS (Basic) | -$0.46 | — | -129.9% |
| EPS (Diluted) | -$0.46 | — | -330.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.1M | -6.6% | -75.2% |
| Accounts Receivable | $3.5M | -12.0% | -58.2% |
| Inventory | $2.1M | -22.8% | -38.5% |
| Current Assets | $11.3M | -11.6% | -65.9% |
| Total Assets | $14.0M | -11.3% | -63.6% |
| Current Liabilities | $37.3M | -3.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.2M | — | +66.0% |
| Financing Cash Flow | $2.9M | — | -80.2% |
| +134.4% |
| Long-term Debt | $0 | — | -100.0% |
| Total Liabilities | $91.9M | -1.1% | -15.1% |
| Stockholders' Equity | -$77.9M | -0.9% | -11.6% |